Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2005Journal of Clinical InvestigationOpen Access

SOCS2 negatively regulates growth hormone action in vitro and in vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

CGChristopher J. GreenhalghUniversity of North Carolina at Chapel HillERElizabeth Rico-BautistaCrinetics Pharmaceuticals (United States)MLMattias LorentzonNational Academy of Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Greenhalgh et al. (2005) studied this question.

synapsesocial.com/papers/6a70152d2163a0a01bc44bbdhttps://doi.org/10.1172/jci22710
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of Tyrosine Residues in the Intracellular Domain of the Growth Hormone Receptor Required for Transcriptional Signaling and Stat5 Activation1996 · 113 citations
  2. 2Long-term experience with GH replacement therapy: efficacy and safety2003 · 122 citations
  3. 3Gene Expression Profiling of Androgen Deficiency Predicts a Pathway of Prostate Apoptosis that Involves Genes Related to Oxidative Stress2002 · 101 citations
  4. 4Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.1994 · 338 citations
  5. 5Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency11998 · 81 citations